The largest database of trusted experimental protocols

2 protocols using glutamate plus

1

Placental Explants Exposure to mRNA Vaccines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Placental biopsies were washed in Cytowash (consisting of DME/H-21 (Gibco), 2.5% fetal bovine serum (Hyclone), 1% glutamine plus (Atlanta Biologicals), 1% penicillin/streptomycin (Invitrogen), and 1% gentamicin (Gibco) 38 (link) and dissected into 1.0 cm2 chorionic villi explants. A single villus was placed in one well of a 24-well plate containing 0.5 ml of prewarmed cell free media [DME/H-21, 2% Nutridoma (Roche), 1% sodium pyruvate (Sigma), 1% Hepes buffer (Invitrogen), 1% glutamate plus (Atlanta Biologicals), and 1% penicillin/streptomycin (Invitrogen)] with 10% fetal bovine serum and incubated at 37°C in 5% CO2/95% for 30 minutes. Vaccine mixtures for explant exposure were then prepared such that final vaccine concentrations were: BNT162b2 and mRNA-1273 vaccine 0.1 μg/mL and 1 μg/mL, as well as control medium. Testing concentrations were based on estimates of localized circulating levels of mRNA vaccines in organs of mice vaccinated for influenza 28 (link). Explants were exposed for 0.5 or 4 hours and incubated at 37°, after which 200 ul of supernatant were collected and stored at −4°C for cytokine analysis. Exposed explants were washed in PBS and then stored at −80 °C until RNA extraction, or formalin-fixed for 24 hours at room temperature, then washed in 70% ethanol and stored at −4°C until undergoing paraffin embedding.
+ Open protocol
+ Expand
2

Placental Explant Exposure to mRNA Vaccines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Placental biopsies were washed in Cytowash (consisting of DME/H-21 (Gibco), 2.5% fetal bovine serum (HyClone), 1% glutamine plus (Atlanta Biologicals, Minneapolis, MN), 1% penicillin/streptomycin (Invitrogen), and 1% gentamicin (Gibco)42 (link) and dissected into 1.0 cm2 chorionic villi explants. A single villus was placed in one well of a 24-well plate containing 0.5 mL of prewarmed cell free media [DME/H-21, 2% Nutridoma (Roche, Basel, Switzerland), 1% sodium pyruvate (Sigma-Aldrich, St. Louis, MO), 1% HEPES buffer (Invitrogen), 1% glutamate plus (Atlanta Biologicals), and 1% penicillin/streptomycin (Invitrogen)] with 10% fetal bovine serum and incubated at 37°C in 5% CO2/95% O2 for 30 min. Vaccine mixtures for explant exposure were then prepared such that final vaccine concentrations were: BNT162b2 and mRNA-1273 vaccine 0.1 μg/mL and 1 μg/mL, as well as control medium. Testing concentrations were based on estimates of localized circulating levels of mRNA vaccines in organs of mice vaccinated for influenza.28 (link) Explants were exposed for 0.5 or 4 h and incubated at 37°C, after which 200 μl of supernatant were collected and stored at -4°C for cytokine analysis. Exposed explants were washed in PBS and then stored at −80°C until RNA extraction, or formalin-fixed for 24 h at room temperature, then washed in 70% ethanol and stored at -4°C until undergoing paraffin embedding.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!